EVOK Evoke Pharma Inc

Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.

$1.70
As of 04/14/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  09/25/2013
Outstanding shares:  32,371,954
Average volume:  621,609
Market cap:   $56,327,200
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30049G104
ISIN:        US30049G1040
Sedol:      BCZS831

---

Valuation   (See tab for details)

---

PE ratio:   -24.84
PB ratio:   14.62
PS ratio:   0.00
Return on equity:   409.21%
Net income %:   -57,144.53%